Industrial Purity Standards For 2,4-Dimethylbromobenzene
- Technical Specification: CAS 583-70-0 requires ≥98% assay for effective cross-coupling reactions.
- Commercial Viability: Bulk procurement strategies significantly reduce cost-per-kg compared to laboratory grades.
- Quality Assurance: Comprehensive COA documentation is essential for regulatory compliance in pharmaceutical synthesis.
In the realm of advanced organic synthesis, the reliability of starting materials dictates the success of downstream applications. 2,4-Dimethylbromobenzene (CAS 583-70-0) serves as a critical aryl halide intermediate, utilized extensively in the construction of complex pharmaceutical and agrochemical architectures. For process chemists and procurement officers, understanding the distinction between laboratory-grade reagents and production-grade materials is paramount. As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. adheres to stringent quality controls to ensure consistent batch-to-b reproducibility for large-scale operations.
The chemical identity of this compound is often referenced by several synonyms, including 1-Bromo-2,4-dimethylbenzene and 4-Bromo-m-xylene. Regardless of the nomenclature, the physical properties remain constant: a clear colorless liquid with a molecular weight of 185.06 g/mol. However, the impurity profile can vary significantly depending on the manufacturing process employed. Industrial clients must prioritize suppliers who can guarantee low levels of isomeric byproducts and residual halogens, which can poison catalysts in palladium-coupled reactions.
Defining Industrial vs. Laboratory Purity for Aryl Bromides
When evaluating specifications for aryl bromides, the threshold for industrial purity differs markedly from academic standards. Laboratory suppliers often provide quantities in grams with purity claims around 97%, which may suffice for milligram-scale screening but fails under the thermodynamics of kilogram-scale reactors. Industrial grades typically demand an assay of ≥98% or ≥99%, with specific limits on water content and related substances.
Impurities such as 2,5-dimethylbromobenzene or unreacted m-xylene can alter reaction kinetics and complicate purification steps during workup. For high-value API synthesis, even trace contaminants can affect crystallization profiles or introduce genotoxic impurities. Therefore, securing a supply chain that offers transparent gas chromatography (GC) data is essential. Buyers should request detailed impurity profiles rather than relying solely on a single purity percentage.
COA Requirements for Bulk 2,4-Dimethylbromobenzene Shipments
A Certificate of Analysis (COA) is the foundational document for quality assurance in bulk chemical procurement. For 2,4-Dimethylbromobenzene, a compliant COA must include verified data on physical constants, chemical assay, and safety parameters. Below is a standard specification table expected for industrial-grade shipments:
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 583-70-0 | N/A |
| Appearance | Clear Colorless Liquid | Visual |
| Purity (GC Area %) | ≥ 98.0% | GC-MS |
| Boiling Point | 214 °C | Distillation |
| Density | 1.37 g/mL at 25 °C | ASTM D4052 |
| Water Content | ≤ 0.1% | Karl Fischer |
Procurement teams should verify that the COA is batch-specific and signed by a qualified quality control manager. Discrepancies in density or refractive index can indicate bulk contamination that GC might miss. Furthermore, stability data should be reviewed to ensure the material remains within specification during transit and storage, particularly given its classification as a combustible liquid.
Impact of ≥98% Assay on Downstream Pharmaceutical Synthesis
The efficiency of cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig aminations, is heavily dependent on the quality of the electrophile. When sourcing high-purity 2,4-Dimethylbromobenzene, buyers should consider the impact of the synthesis route on the final impurity profile. Common production methods involve the bromination of m-xylene using N-bromosuccinimide (NBS) or elemental bromine with a catalyst.
Residual acids or oxidizing agents from the synthesis route can degrade sensitive catalysts, leading to lower yields and increased formation of homocoupling byproducts. In a commercial setting, a 2% drop in yield due to poor starting material quality can translate to significant financial loss when scaled to tons. Consequently, the bulk price should be evaluated against the cost of purification and potential yield loss. Investing in higher purity upfront often results in a lower total cost of ownership.
For pharmaceutical applications, regulatory compliance requires full traceability of raw materials. Suppliers must adhere to ISO standards and provide safety data sheets (SDS) that align with global harmonized systems. The material is classified as an irritant (GHS07), requiring appropriate personal protective equipment during handling. Storage conditions should maintain the product in a sealed, dry environment at room temperature to prevent hydrolysis or oxidation.
Safety and Handling Protocols
Safe handling of aryl bromides is critical for maintaining operational integrity. The following safety parameters outline the necessary precautions for industrial handling:
| Hazard Class | Signal Word | Precautionary Statements |
|---|---|---|
| Irritant (Xi) | Warning | P261, P264, P271, P280 |
| Hazard Statements | H315 (Skin Irritation), H319 (Eye Irritation), H335 (Respiratory Irritation) | |
| PPE Requirements | Eyeshields, Gloves, Type ABEK Respirator Filter | |
| Storage Class | 10 - Combustible Liquids | |
Proper ventilation and spill containment procedures must be established in accordance with local environmental regulations. Waste disposal should follow guidelines for halogenated organic compounds to prevent environmental contamination.
Conclusion
Selecting the right partner for chemical intermediates is a strategic decision that impacts production efficiency and product quality. NINGBO INNO PHARMCHEM CO.,LTD. stands ready to support global clients with reliable supply chains and technically superior materials. By prioritizing verified industrial purity and comprehensive documentation, manufacturers can mitigate risk and optimize their synthetic workflows. For detailed specifications and volume quotations, direct engagement with the manufacturing team is recommended to align technical requirements with commercial objectives.